Literature DB >> 4796282

Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?

B Costall, R J Naylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4796282     DOI： 10.1007/bf00428687

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  9 in total

1.  Proceedings: Behavioural and biochemical evidence for cerebral dopamine receptor blockade by metoclopramide in rodents.

Authors:  P Jenner; C D Marsden; E Peringer
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  BRL 20596, a novel anilide with central dopamine antagonist activity.

Authors:  W Campbell; M S Clark; P J Mitchell; P L Needham; J M Semple
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum.

Authors:  B Costall; R J Naylor; J C Pettit
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.

Authors:  D Tarsy; J D Parkes; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-04       Impact factor: 10.154

5.  Antagonism of the renal vasodilator activity of dopamine by metoclopramide.

Authors:  R A Hahn; J R Wardell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

6.  The synaptic significance of metoclopramide induced dyskinetic-dystonic head and neck movements in pregnancy.

Authors:  J J Askenasy; M Streifler; S Felner
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

Review 7.  The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness.

Authors:  R Miller
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility.

Authors:  R S Alphin; A G Proakis; C A Leonard; W L Smith; W N Dannenburg; W J Kinnier; D N Johnson; L F Sancilio; J W Ward
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

9.  The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide.

Authors:  F Brown; W Campbell; M S Clark; D S Graves; M S Hadley; J Hatcher; P Mitchell; P Needham; G Riley; J Semple
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.